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Introduction
Tuberculosis (TB) is a frequent disease among People Liv-
ing with HIV/ AIDS (PLHAs) in Nepal.Prevalence is more
than 70% and TB is still a major killer in PLHAs and first
Oppertunistic Infection (OI) among PLHAs. We intend to
assess prevalence, clinical features, treatment outcome,
resistant to first line antitubercular drugs and survival of
PLHAs with TB.
Method
A longitudinal retrospective-prospective study of clinical
records from co-infected before and after Antiretroviral
Treatment (ART) with confirmed TB diagnosis or clinical
suspect was done. Sensitivity of drugs performed in cases
of Treatment failure or epidemiological issues. Treatment
success was defined as cure; poor outcome included
incomplete treatment, failure or death.
Results
8913 patients since 2007 to 2009 admitted at Nava Kiran
Super Speciality Center, 680 clients were co-infected. TB
incidence was 68.9%. Age ranged from 16 to 61 years, 75%
were under 40 years and 520 clients that is 76.47% were
male. HIV infection route; intravenous drug users 59.26%,
heterosexual 28.32%, MSM 8.15%, and others were
28.32%. Mean CD4 was 150 cells/cml. TB was first inci-
dent in 59.6%. Pulmonary TB account 590 (86.76%) with
acid fast smear positive in 87% and extrapulmonary TB
counted 90 (13.23%). Multiple Drug Resistant (MDR)
TB account 52 (8.8%) of pulmonary TB. In pulmonary TB
complete cure was obtained in 64.03% and 22.97% in
MDR TB inspite of adequate treatment. Success was high
in Pulmonary TB.
Conclusion
TB is devastating situation in PLHAs of Nepal. A high
suspect, early diagnosis and documented sensitivity
improve the outcome and diminished sequel and
mortality.
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